SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001628280-22-017746
Filing Date
2022-06-22
Accepted
2022-06-22 07:32:49
Documents
21
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 40-F cybin-form40xfannualreport.htm 40-F 82048
2 EX-99.1 annualinformationformaif-c.htm EX-99.1 990408
3 EX-99.2 cybinincfs-q4x22xmarch3120.htm EX-99.2 799342
4 EX-99.3 cybin-mdaq4xmarch312022.htm EX-99.3 853580
5 EX-99.4 exhibit994-ceo.htm EX-99.4 6806
6 EX-99.5 exhibit995cfo.htm EX-99.5 6888
7 EX-99.6 exhibit996-ceocert.htm EX-99.6 3813
8 EX-99.7 exhibit997-cfo.htm EX-99.7 4226
9 EX-99.8 ziefmansconsent40-f.htm EX-99.8 4934
10 image1a.jpg GRAPHIC 8938
11 image1b.jpg GRAPHIC 3156
12 image2a.jpg GRAPHIC 35507
13 image2b.jpg GRAPHIC 8938
14 image3.jpg GRAPHIC 3156
15 image_0.jpg GRAPHIC 50627
16 image_0a.jpg GRAPHIC 185
17 image_1.jpg GRAPHIC 41858
18 image_1a.jpg GRAPHIC 253
19 imagea.jpg GRAPHIC 134569
20 imageb.jpg GRAPHIC 35507
21 imagec.jpg GRAPHIC 134569
  Complete submission text file 0001628280-22-017746.txt   3383972
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 40-F | Act: 34 | File No.: 001-40673 | Film No.: 221030004
SIC: 2834 Pharmaceutical Preparations